1. Home
  2. FCCO vs SABS Comparison

FCCO vs SABS Comparison

Compare FCCO & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$29.23

Market Cap

228.0M

Sector

Finance

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.83

Market Cap

201.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCCO
SABS
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.0M
201.4M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FCCO
SABS
Price
$29.23
$3.83
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.80
AVG Volume (30 Days)
59.0K
767.0K
Earning Date
04-22-2026
03-09-2026
Dividend Yield
2.21%
N/A
EPS Growth
36.46
N/A
EPS
2.47
N/A
Revenue
$922,000.00
N/A
Revenue This Year
$30.67
N/A
Revenue Next Year
$5.87
N/A
P/E Ratio
$11.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.46
$1.00
52 Week High
$31.50
$6.60

Technical Indicators

Market Signals
Indicator
FCCO
SABS
Relative Strength Index (RSI) 56.44 47.29
Support Level $29.10 $3.54
Resistance Level $29.74 $4.16
Average True Range (ATR) 0.81 0.26
MACD 0.15 -0.02
Stochastic Oscillator 76.00 10.96

Price Performance

Historical Comparison
FCCO
SABS

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: